Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?

Atherosclerosis

Volumn 191, Issue 2, 2007, Pages 355-361

  Wong, Cindy W ^a   Christen, Thomas ^a   Pfenniger, Anna ^a   James, Richard W ^b   Kwak, Brenda R ^a  

^a WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Atherosclerosis; Connexin; Coronary artery disease; Genetic polymorphism; Myocardial infarction

Indexed keywords

CONNEXIN 37; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ALLELISM; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SWITZERLAND;

AGED; ALLELES; CONNEXINS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CYTOSINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWITZERLAND; THYMINE;

EID: 33947163981     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.03.031     Document Type: Article

References (30)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Jefferson B.K., and Topol E.J. Molecular mechanisms of myocardial infarction. Curr Probl Cardiol 30 (2005) 333-374
3. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part II. Circulation 108 (2003) 1772-1778
4. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part I. Circulation 108 (2003) 1664-1672
5. Aikawa M., and Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 13 (2004) 125-138
6. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
7. Scheuner M.T. Genetic predisposition to coronary artery disease. Curr Opin Cardiol 16 (2001) 251-260
8. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis. Part I. New genes and pathways. Circulation 110 (2004) 1868-1873
9. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis. Part II. Clinical implications. Circulation 110 (2004) 2066-2071
10. Vivanco F., Martin-Ventura J.L., Duran M.C., et al. Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 4 (2005) 1181-1191
11. Tuomisto T.T., Binder B.R., and Yla-Herttuala S. Genetics, genomics and proteomics in atherosclerosis research. Ann Med 37 (2005) 323-332
12. Boerma M., Forsberg L., Van Zeijl L., et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 246 (1999) 211-218
13. Yeh H.I., Chou Y., Liu H.F., Chang S.C., and Tsai C.H. Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 81 (2001) 251-255
14. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
15. Hirashiki A., Yamada Y., Murase Y., et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42 (2003) 1429-1437
16. Yamada Y., Ichihara S., Izawa H., Tanaka M., and Yokota M. Genetic risk for coronary artery disease in individuals with or without type 2 diabetes. Mol Genet Metab 81 (2004) 282-290
17. Wang Q., Rao S., Shen G.Q., et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 74 (2004) 262-271
18. Listi F., Candore G., Lio D., et al. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 102 (2005) 269-271
19. Harris A.L. Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 34 (2001) 325-472
20. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., and Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83 (2003) 1359-1400
21. Wei C.J., Xu X., and Lo C.W. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20 (2004) 811-838
22. Wong C.W., Christen T., and Kwak B.R. Connexins in leukocytes: shuttling messages?. Cardiovasc Res 62 (2004) 357-367
23. Severs N.J., Rothery S., Dupont E., et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 52 (2001) 301-322
24. Wong C.W., Christen T., Foglia B., et al. Eliminating connexin37 enhances atherosclerosis in apolipoprotein E-deficient mice. Circulation 110 (2004) III-38/39 (abstr)
25. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
26. James R.W., Leviev I., and Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101 (2000) 2252-2257
27. Leviev I., Righetti A., and James R.W. Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J Mol Med 79 (2001) 457-463
28. James R.W., and Pometta D. Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes 39 (1990) 1158-1164
29. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
30. Watson K.E., and Topol E.J. Pathobiology of atherosclerosis: are there racial and ethnic differences?. Rev Cardiovasc Med 5 Suppl 3 (2004) S14-S21